Integral Derivatives’s Cognex CGNX Stock Holding History

Integral Derivatives’s Portfolio CGNX Stock Details CGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-7,000	Closed	-$297K	–	1144
2017 Q2	$297K	Buy	+7,000	New	+$311K	0.01%	864

Other funds holding CGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Joho Capital New York $373M AUM 18.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Integral Derivatives's CGNX Position: Q3 2017 in Review

Integral Derivatives sold out of Cognex (CGNX) in Q3 2017, closing a stake of 7,000 shares — an estimated $297K sold.

Integral Derivatives first reported a position in CGNX in Q2 2017 and held it in 1 quarter. The position peaked at $297K in Q2 2017. 411 funds tracked by Wall St. Rank hold CGNX as of Q3 2017.

Integral Derivatives reported no remaining Cognex position as of Q3 2017 after selling out during the quarter.
Integral Derivatives sold 7,000 Cognex shares in Q3 2017, an estimated $297K.
Integral Derivatives first reported a position in Cognex in Q2 2017 and held it in 1 quarter.
Integral Derivatives's Cognex position peaked at $297K in Q2 2017.
411 funds tracked by Wall St. Rank held Cognex as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.